Medium materiality6/10
Relay Therapeutics price target raised to $29 from $28 at Wells Fargo
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo raises Relay Therapeutics price target to $29 from $28; current price $20.74; price change since signal -5.01.
- Wells Fargo raises RLAY target to $29; price $20.74; -5.01 since signal.
Key facts
- 01
Target: $29
- 02
Posted price: $20.74
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.